{
    "Trade/Device Name(s)": [
        "ETEST Piperacillin/Tazobactam",
        "ETEST P/T"
    ],
    "Submitter Information": "bioMerieux SA",
    "510(k) Number": "K190154",
    "Predicate Device Reference 510(k) Number(s)": [
        "K172150"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "JWY"
    ],
    "Summary Letter Date": "January 29, 2019",
    "Summary Letter Received Date": "January 30, 2019",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 866.1640"
    ],
    "Regulation Name(s)": [
        "Antimicrobial susceptibility test powder"
    ],
    "Analyte Class(es)": [
        "microbiology"
    ],
    "Analyte(s)": [
        "Piperacillin",
        "Tazobactam"
    ],
    "Specimen Type(s)": [
        "Non-fastidious Gram-negative aerobic bacteria",
        "Gram-positive aerobic bacteria",
        "Fastidious bacteria"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [
        "Manual antimicrobial susceptibility testing",
        "Antibiotic gradient diffusion"
    ],
    "Methodologies": [
        "Minimum Inhibitory Concentration determination"
    ],
    "Submission Type(s)": [
        "Assay",
        "Strip",
        "Reagent"
    ],
    "Document Summary": "FDA 510(k) summary for ETEST Piperacillin/Tazobactam manual gradient diffusion strip assay for MIC determination of various aerobic bacteria",
    "Indications for Use Summary": "Quantitative determination of MIC for Piperacillin/Tazobactam against aerobic Gram-negative and Gram-positive bacteria using a manual gradient strip method",
    "fda_folder": "Microbiology"
}